Studies of Interferon Production and Natural Killing by Lymphocytes from Multiple Sclerosis Patients (Q40076141)

17 September 2017

1 reference

title

Studies of interferon production and natural killing by lymphocytes from multiple sclerosis patients (English)

1 reference

17 September 2017

Studies of Interferon Production and Natural Killing by Lymphocytes from Multiple Sclerosis Patients (English)

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

1 August 2023

main subject

multiple sclerosis

0 references

immunologic cytotoxicity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6085226

history and philosophy of science

1 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

1 August 2023

author name string

P. A. Neighbour

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6085226

1 August 2023

language of work or name

English

0 references

publication date

1 January 1984

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1984.tb14789.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1984.tb14789.x/fullpdf

1 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Annals of the New York Academy of Sciences

1 August 2023

published in

1 reference

17 September 2017

436

1 reference

17 September 2017

181-191

1 reference

UCLA conference. Interferon: immunobiology and clinical significance

17 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14789.X

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14789.X

Increased susceptibility to cytomegalovirus infection in beige mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14789.X

Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14789.X

Antibody-dependent cellular cytotoxicity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14789.X

Recycling and target binding capacity of human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14789.X

Natural Killer Cell Activity in Patients with Multiple Sclerosis: Interferon and Plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14789.X

Interferon modulation of natural killer cell activity

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Natural killing can be independent of interferon generated in vitro

1 August 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Interferon responses of leukocytes in multiple sclerosis

1 August 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Genetic influence on natural cytotoxicity and interferon production in multiple sclerosis studies in monozygotic discordant twins

1 August 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Lack of correlation between impaired Interferon production and natural killer activity of lymphocytes in multiple sclerosis

1 August 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

1 August 2023

18

2

218

Khaletskaia E. V.

1981

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

PPD-, PWM-, and PHA-induced interferon in stable multiple sclerosis: association with HLA-Dw2 antigen and clinical variables

1 August 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Defective production of interferon-alpha associated with HLA-DW2 antigen in stable multiple sclerosis

1 August 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natu

1 August 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patients

1 August 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Association between HLA B7,DR2 and dysfunction of natural- and antibody- mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis

1 August 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Cytotoxic activity of peripheral blood and cerebrospinal fluid lymphocytes from patients with multiple sclerosis and other neurological diseases. Analysis at the single cell level using morphological and surface marker phenotype criteria

1 August 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Natural killer cells in systemic lupus erythematosus. Abnormal numbers and functional immaturity of HNK-1+ cells

1 August 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Antibodies to glycosphingolipids in patients with multiple sclerosis

1 August 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

A glycolipid on the surface of mouse natural killer cells

1 August 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells

1 August 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Lymphocyte adherence in multiple sclerosis. Role of monocytes and increased sensitivity of MS lymphocytes to prostaglandin E

1 August 2023

40

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

Natural killing activity in sjögren's syndrome

1 August 2023

41

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14789.X

1 August 2023

Identifiers

1 reference

17 September 2017

1 reference